CMV eVLP: Completed Phase I enrollment

VBI completed enrollment of 128 CMV-seronegative healthy volunteers in a placebo-controlled, Canadian Phase I trial evaluating unadjuvanted VBI-1501A and 3 doses of adjuvanted VBI-1501A given at month...